Anti-Clostridium difficile monoclonal antibody (MedImmune)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnti-Clostridium difficile monoclonal antibody (MedImmune)
Drug Alias Name抗难辨梭状芽孢杆菌单克隆抗体C. difficile antibodies反梭菌单克隆抗体CDAD antitoxin monoclonal antibodies
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionToxin B inhibitors
TargetsToxin B
Therapy Area/IndicationsDiarrheaClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesProgenics Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedimmune LlcProgenics Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsDiarrheaClostridium Infections

Other Information

ATC CodeN/A
Related LinksN/A